{"id":"ceftriaxone-sodium-metronidazole","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Diarrhea"},{"rate":"3-8","effect":"Nausea"},{"rate":"2-5","effect":"Headache"},{"rate":"1-3","effect":"Rash"},{"rate":"1-2","effect":"Hypersensitivity reactions"},{"rate":"<1","effect":"Pseudomembranous colitis"},{"rate":"5-10","effect":"Metallic taste (metronidazole)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ceftriaxone sodium binds to penicillin-binding proteins and inhibits cross-linking of peptidoglycan in bacterial cell walls, leading to cell lysis. Metronidazole is a prodrug that generates reactive intermediates in anaerobic bacteria, causing DNA strand breaks and cell death. Together, they provide synergistic coverage for mixed aerobic-anaerobic infections.","oneSentence":"This combination uses a third-generation cephalosporin to inhibit bacterial cell wall synthesis and a nitroimidazole to disrupt anaerobic bacterial DNA, providing broad-spectrum coverage against aerobic gram-negative, gram-positive, and anaerobic organisms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:40:50.705Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Intra-abdominal infections (including peritonitis and appendicitis)"},{"name":"Gynecological infections"},{"name":"Anaerobic bacterial infections with mixed aerobic-anaerobic flora"},{"name":"Prophylaxis in abdominal and gynecological surgery"}]},"trialDetails":[{"nctId":"NCT06396078","phase":"PHASE4","title":"Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-07-18","conditions":"Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth","enrollment":56},{"nctId":"NCT05821478","phase":"PHASE3","title":"Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients","status":"RECRUITING","sponsor":"Institut Pasteur","startDate":"2025-05-22","conditions":"Hidradenitis Suppurativa","enrollment":92},{"nctId":"NCT06950229","phase":"NA","title":"Povidone Iodine Versus Normal Saline in Preoperative Vaginal Cleansing Before Caesarean Section","status":"COMPLETED","sponsor":"Federal Teaching Hospital Abakaliki","startDate":"2020-10-06","conditions":"Povidone Iodine, Normal Saline, Pre-operative","enrollment":224},{"nctId":"NCT06828952","phase":"","title":"Risk Factors of Failure of Conservative Treatment in Acute Non Complicated Appendicitis","status":"NOT_YET_RECRUITING","sponsor":"Ahmed Mohammed Hussein Sayed","startDate":"2025-06-22","conditions":"Conservative Management","enrollment":100},{"nctId":"NCT05812820","phase":"NA","title":"Effects of Probiotic in Treatment of Persistent Diarrhea in Children","status":"COMPLETED","sponsor":"National Children's Hospital, Vietnam","startDate":"2022-07-01","conditions":"Diarrhea","enrollment":165},{"nctId":"NCT06572761","phase":"PHASE3","title":"A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-09","conditions":"Previable Labour With Intact Membranes","enrollment":350},{"nctId":"NCT06349122","phase":"PHASE4","title":"Screen-and-treat Strategy for Vaginal Flora Abnormalities in Pregnant Women at High Risk of Preterm Birth","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2024-08","conditions":"Bacterial Vaginosis, Vaginal Dysbiosis, Premature Delivery","enrollment":1292},{"nctId":"NCT05724628","phase":"PHASE1","title":"Non-operative vs. Operative Management of Acute Appendicitis in Vulnerable Patient Populations","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2023-10","conditions":"Acute Appendicitis","enrollment":""},{"nctId":"NCT03289351","phase":"PHASE4","title":"Two Different Antibiotics Versus One Antibiotic for Pediatric Perforated Appendicitis","status":"COMPLETED","sponsor":"Phoenix Children's Hospital","startDate":"2017-05-22","conditions":"Perforated Appendicitis, Postoperative Infection","enrollment":162},{"nctId":"NCT04977882","phase":"EARLY_PHASE1","title":"Abdominal Drainage, Postoperative Antibiotico-prophylaxis and CME With D3 Lyphadenectomy Effect on Gastrointestinal Function in Laparoscopic Right Hemicolectomy With Intracorporeal Anastomosis for Right Colon Cancer","status":"COMPLETED","sponsor":"University of Rome Tor Vergata","startDate":"2020-10-01","conditions":"Colon Cancer","enrollment":36},{"nctId":"NCT05943223","phase":"PHASE2","title":"Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA)","status":"UNKNOWN","sponsor":"McMaster Children's Hospital","startDate":"2024-01","conditions":"Appendicitis Perforated","enrollment":16},{"nctId":"NCT02800785","phase":"NA","title":"The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial","status":"COMPLETED","sponsor":"University of Washington","startDate":"2016-05","conditions":"Appendicitis","enrollment":1552},{"nctId":"NCT05511194","phase":"NA","title":"Safety and Efficacy of ERAS Therapeutic Protocol for Complicated Appendicitis in Children","status":"UNKNOWN","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2022-10-01","conditions":"Enhanced Recovery After Surgery, Appendicitis, Children, Only","enrollment":40},{"nctId":"NCT05352087","phase":"NA","title":"Effect Of Early Versus Delayed Laparoscopic Cholecystectomy In Patients With Grade II Cholecystitis","status":"COMPLETED","sponsor":"Tepecik Training and Research Hospital","startDate":"2019-12-14","conditions":"Cholecystitis","enrollment":92},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT00462020","phase":"NA","title":"Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2007-03","conditions":"Perforated Appendicitis","enrollment":102},{"nctId":"NCT03794765","phase":"PHASE2","title":"Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-04-01","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases, Acute Severe Colitis","enrollment":50},{"nctId":"NCT03174236","phase":"PHASE3","title":"First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2017-09-04","conditions":"Malnutrition Severe, Antibiotic Resistance, Antibiotic Toxicity","enrollment":2000},{"nctId":"NCT03080103","phase":"","title":"Appendectomy Versus Conservative Treatment for Uncomplicated Acute Appendicitis","status":"COMPLETED","sponsor":"Mauro Podda","startDate":"2017-06-01","conditions":"Acute Appendicitis, Appendicitis Recurrent, Appendectomy","enrollment":300},{"nctId":"NCT03665376","phase":"NA","title":"Feasibility and Efficacy of Enhanced Recovery After Surgery (ERAS) on Length of Stay Among Laparotomy Patients at Mbarara Regional Referral Hospital","status":"COMPLETED","sponsor":"Mbarara University of Science and Technology","startDate":"2017-06-01","conditions":"Laparotomy","enrollment":33},{"nctId":"NCT01160640","phase":"PHASE2","title":"The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)","status":"COMPLETED","sponsor":"Harold Wiesenfeld","startDate":"2010-11","conditions":"Pelvic Inflammatory Disease","enrollment":233},{"nctId":"NCT03266380","phase":"","title":"Risk Factors and Common Preventive Measures for Ventilator Associated Pneumonia in Patients With Severe Traumatic Brain Injury","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2018-01-01","conditions":"Ventilator Associated Pneumonia","enrollment":80},{"nctId":"NCT02746276","phase":"PHASE2","title":"Optimising Antibiotic Treatment for Sick Malnourished Children","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2016-04-01","conditions":"Malnutrition","enrollment":81},{"nctId":"NCT01254344","phase":"PHASE3","title":"Efficacy and Safety of Ertapenem Sodium (MK-0826) Following Colorectal Surgery in Chinese Adults (MK-0826-056)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-12","conditions":"Infection, Surgical Site Infection","enrollment":599},{"nctId":"NCT00481702","phase":"PHASE3","title":"A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2001-12","conditions":"Intra-abdominal Infection","enrollment":300},{"nctId":"NCT00157898","phase":"PHASE4","title":"A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-01","conditions":"Complicated Intra-abdominal Infection","enrollment":134},{"nctId":"NCT02736682","phase":"PHASE4","title":"Single Dose Ceftriaxone and Metronidazole Versus Multiple Doses for Antibiotic Prophylaxis at Elective Cesarean Section.","status":"COMPLETED","sponsor":"Makerere University","startDate":"2015-09","conditions":"Post Operative Infections","enrollment":174},{"nctId":"NCT00769171","phase":"PHASE3","title":"Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-10","conditions":"Infection, Intra-abdominal","enrollment":364},{"nctId":"NCT01473836","phase":"PHASE3","title":"A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection","status":"COMPLETED","sponsor":"Pfizer","startDate":"2011-11","conditions":"Intra-abdominal Infections","enrollment":38},{"nctId":"NCT00230971","phase":"PHASE4","title":"Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2005-10","conditions":"Appendicitis, Cholecystitis, Diverticulitis","enrollment":473},{"nctId":"NCT00195351","phase":"PHASE4","title":"Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2005-09","conditions":"Appendicitis, Cholecystitis, Cross Infection","enrollment":467},{"nctId":"NCT01602874","phase":"PHASE3","title":"Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia","status":"WITHDRAWN","sponsor":"Pfizer","startDate":"2011-01","conditions":"Community Acquired Bacterial Pneumonia, Complicated Intra-Abdominal Infection","enrollment":""},{"nctId":"NCT01678365","phase":"PHASE4","title":"Safety and Efficacy of Single Daily Dose of Ceftriaxone and Metronidazole for Treatment of Complicated Appendicitis in Children","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2008-07","conditions":"Complicated Appendicitis","enrollment":43},{"nctId":"NCT00914888","phase":"PHASE3","title":"Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia","status":"WITHDRAWN","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2011-01","conditions":"Community Acquired Bacterial Pneumonia, Complicated Intra-Abdominal Infection","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"ceftriaxone sodium + metronidazole","genericName":"ceftriaxone sodium + metronidazole","companyName":"Wyeth is now a wholly owned subsidiary of Pfizer","companyId":"wyeth-is-now-a-wholly-owned-subsidiary-of-pfizer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination uses a third-generation cephalosporin to inhibit bacterial cell wall synthesis and a nitroimidazole to disrupt anaerobic bacterial DNA, providing broad-spectrum coverage against aerobic gram-negative, gram-positive, and anaerobic organisms. Used for Intra-abdominal infections (including peritonitis and appendicitis), Gynecological infections, Anaerobic bacterial infections with mixed aerobic-anaerobic flora.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}